Use patient-reported outcomes to guide product development and improve market access initiatives. Leverage the healthcare consumer perspective to strengthen product value propositions during regulatory approval and reimbursement discussions and to gain insight to potential commercial success.
Benchmark your medical publications team’s performance against other drug manufacturers’ metrics. Demonstrate medical publications' value to the organization, boost investment in the department and meet diverse stakeholder needs for clinical and scientific information.
Discover how life science companies build effective teams and efficient infrastructure to meet payers’ growing needs. Coordinate clinical, market access and medical affair groups to build successful managed markets organizations. Communicate consistent messages that justify current prices and present their products’ value to payers.
Benchmark your medical device HEOR group performance against your competitors, with real-company examples and case studies. Learn how HEOR teams can best support Class II and Class III medical devices throughout their lifecycle. This report will help you to define best practices for making the most out of your HEOR studies to drive reimbursement decisions.
Augment social media and mobile app use to enhance brand value. Find out how top pharmaceutical companies determine resource levels needed in aligning digital marketing with brand/corporate team goals.
Explore new strategies and tactics that sales forces use to overcome access barriers and provide customer value in today’s increasingly restrictive landscape.
Obtain hard-to-find Big Data benchmarks. Learn how top companies leverage health outcomes, social media, patient-reported outcomes and other real-world data to drive a broad range of prospective Big Data strategies.
Build up regulatory affairs' profile within your company, solidify two-way relationships with regulatory agencies and coordinate global submission strategy with local regulatory affairs teams. Strengthen clinical and commercial teams' ability to secure product approval and win the best possible reimbursement status.
Set fair-market value compensation and protocols for healthcare providers in the Middle East, gathered from top pharmaceutical companies operating in the region.